Constance Keyserling
Chief Operating Officer en ABIONYX PHARMA .
Perfil
Constance Keyserling is currently the Director of Clinical Development & Operations at ABIONYX Pharma SA. Previously, she held positions as the Senior Director of Operations at Esperion Therapeutics, Inc., Manager of Clinical Research Operations at Pfizer Inc., Vice President of Development Operations at QuatRx Pharmaceuticals Co., and Manager of Clinical Research Operations at Parke, Davis & Co. LLC.
She obtained her graduate degree from Harvard University in 1984.
Cargos activos de Constance Keyserling
| Empresas | Cargo | Inicio |
|---|---|---|
| ABIONYX PHARMA | Chief Operating Officer | - |
Antiguos cargos conocidos de Constance Keyserling.
| Empresas | Cargo | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
| ESPERION THERAPEUTICS, INC. | Chief Operating Officer | - |
| Parke, Davis & Co. LLC | Corporate Officer/Principal | - |
QuatRx Pharmaceuticals Co.
 QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Corporate Officer/Principal | - |
Formación de Constance Keyserling.
| Harvard University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| ESPERION THERAPEUTICS, INC. | Health Technology |
| ABIONYX PHARMA | Health Technology |
| Empresas privadas | 2 |
|---|---|
QuatRx Pharmaceuticals Co.
QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Health Technology |
| Parke, Davis & Co. LLC |
- Bolsa de valores
- Insiders
- Constance Keyserling
